These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 17190733
1. Progress report on The Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) study: status at February 2004. Hosohata K, Saito S, Asayama K, Ohkubo T, Kikuya M, Metoki H, Obara T, Kato T, Hashimoto J, Totsune K, Miura Y, Imai Y, HOMED-BP Study Group. Clin Exp Hypertens; 2007 Jan; 29(1):69-81. PubMed ID: 17190733 [Abstract] [Full Text] [Related]
2. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug. Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M. Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208 [Abstract] [Full Text] [Related]
3. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring. Karotsis AK, Symeonidis A, Mastorantonakis SE, Stergiou GS, Home-Di-Plus Study Group. Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064 [Abstract] [Full Text] [Related]
4. Efficacy of combination antihypertensive therapy with low-dose indapamide: assessment by blood pressure self-monitoring at home. Hashimoto J, Hirayama H, Hanasawa T, Watabe D, Asayama K, Metoki H, Kikuya M, Ohkubo T, Totsune K, Imai Y. Clin Exp Hypertens; 2005 May; 27(4):331-41. PubMed ID: 15921070 [Abstract] [Full Text] [Related]
5. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR. Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [Abstract] [Full Text] [Related]
6. The second progress report on the Hypertension Objective treatment based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) study. Saito S, Asayama K, Ohkubo T, Kikuya M, Metoki H, Obara T, Hashimoto J, Totsune K, Miura Y, Imai Y, HOMED-BP Study Group. Blood Press Monit; 2004 Oct; 9(5):243-7. PubMed ID: 15472496 [Abstract] [Full Text] [Related]
7. Progress report on the HOMED-BP Study: hypertension objective treatment based on measurement by electrical devices of blood pressure study. Aoki Y, Asayama K, Ohkubo T, Nishimura T, Kikuya M, Metoki H, Hozawa A, Hashimoto J, Michimata M, Matsubara M, Araki T, Imai Y, HOMED-BP Study Group. Clin Exp Hypertens; 2004 Feb; 26(2):119-27. PubMed ID: 15038622 [Abstract] [Full Text] [Related]
8. Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure. Asayama K, Ohkubo T, Metoki H, Obara T, Inoue R, Kikuya M, Thijs L, Staessen JA, Imai Y, Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP). Hypertens Res; 2012 Nov; 35(11):1102-10. PubMed ID: 22895063 [Abstract] [Full Text] [Related]
9. [Antihypertensive therapy for refractory morning hypertension in patients on peritoneal dialysis]. Kuriyama S, Otsuka Y, Iida R, Kobayashi S, Yamagishi H, Hosoya T. Nihon Jinzo Gakkai Shi; 2005 Nov; 47(1):38-45. PubMed ID: 15754762 [Abstract] [Full Text] [Related]
10. Current status of antihypertensive prescription and associated blood pressure control in Japan. Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M, Umemura S. Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149 [Abstract] [Full Text] [Related]
11. Is renoprotection by angiotensin receptor blocker dependent on blood pressure?: the Saitama Medical School, Albuminuria Reduction in Diabetics with Valsartan (STAR) study. Katayama S, Yagi S, Yamamoto H, Yamaguchi M, Izumida T, Noguchi Y, Inaba M, Inukai K. Hypertens Res; 2007 Jun; 30(6):529-33. PubMed ID: 17664856 [Abstract] [Full Text] [Related]
12. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). JATOS Study Group. Hypertens Res; 2008 Dec; 31(12):2115-27. PubMed ID: 19139601 [Abstract] [Full Text] [Related]
13. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients]. Hanon O, Laroche P, Vidal JS, Pannier B, Postel-Vinay N, Vaisse B, Girerd X. Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025 [Abstract] [Full Text] [Related]
14. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M. Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914 [Abstract] [Full Text] [Related]
15. A comparison of home measurement and ambulatory monitoring of blood pressure in the adjustment of antihypertensive treatment. Niiranen TJ, Kantola IM, Vesalainen R, Johansson J, Ruuska MJ. Am J Hypertens; 2006 May; 19(5):468-74. PubMed ID: 16647616 [Abstract] [Full Text] [Related]
16. The angiotensin receptor blocker eprosartan mesylate reduces pulse pressure in isolated systolic hypertension. Teitelbaum I, Chilvers M, Reiz RJ. Can J Cardiol; 2004 Oct; 20 Suppl C():11C-16C. PubMed ID: 16807618 [Abstract] [Full Text] [Related]
17. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL. Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [Abstract] [Full Text] [Related]
18. [Comparative effects of angiotensin converting enzyme inhibitors and calcium inhibitors related to baseline ambulatory blood pressure. A French multicenter study]. Herpin D, Vaïsse B, Raud-Raynier P, Boijoux C, Pitiot M, Asmar R, Contard S, Gosse P, de Gaudemaris R, Zannad F. Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1235-8. PubMed ID: 1482265 [Abstract] [Full Text] [Related]
19. Differential impact of angiotensin receptor blockers and calcium channel blockers on arterial stiffness. Andreadis EA, Sfakianakis ME, Tsourous GI, Georgiopoulos DX, Fragouli EG, Katsanou PM, Tavoularis EI, Skarlatou MG, Marakomichelakis GE, Ifanti GK, Diamantopoulos EJ. Int Angiol; 2010 Jun; 29(3):266-72. PubMed ID: 20502415 [Abstract] [Full Text] [Related]
20. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis. Fang W, Oreopoulos DG, Bargman JM. Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695 [Abstract] [Full Text] [Related] Page: [Next] [New Search]